Certificate of Analysis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
(12) Patent Application Publication (10) Pub. No.: US 2015/0337275 A1 Pearlman Et Al
US 20150337275A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0337275 A1 Pearlman et al. (43) Pub. Date: Nov. 26, 2015 (54) BOCONVERSION PROCESS FOR Publication Classification PRODUCING NYLON-7, NYLON-7.7 AND POLYESTERS (51) Int. C. CI2N 9/10 (2006.01) (71) Applicant: INVISTATECHNOLOGIES S.a.r.l., CI2P 7/40 (2006.01) St. Gallen (CH) CI2PI3/00 (2006.01) CI2PI3/04 (2006.01) (72) Inventors: Paul S. Pearlman, Thornton, PA (US); CI2P 13/02 (2006.01) Changlin Chen, Cleveland (GB); CI2N 9/16 (2006.01) Adriana L. Botes, Cleveland (GB); Alex CI2N 9/02 (2006.01) Van Eck Conradie, Cleveland (GB); CI2N 9/00 (2006.01) Benjamin D. Herzog, Wichita, KS (US) CI2P 7/44 (2006.01) CI2P I 7/10 (2006.01) (73) Assignee: INVISTATECHNOLOGIES S.a.r.l., (52) U.S. C. St. Gallen (CH) CPC. CI2N 9/13 (2013.01); C12P 7/44 (2013.01); CI2P 7/40 (2013.01); CI2P 13/005 (2013.01); (21) Appl. No.: 14/367,484 CI2P 17/10 (2013.01); CI2P 13/02 (2013.01); CI2N 9/16 (2013.01); CI2N 9/0008 (2013.01); (22) PCT Fled: Dec. 21, 2012 CI2N 9/93 (2013.01); CI2P I3/04 (2013.01); PCT NO.: PCT/US2012/071.472 CI2P 13/001 (2013.01); C12Y 102/0105 (86) (2013.01) S371 (c)(1), (2) Date: Jun. 20, 2014 (57) ABSTRACT Embodiments of the present invention relate to methods for Related U.S. Application Data the biosynthesis of di- or trifunctional C7 alkanes in the (60) Provisional application No. -
Toxicological Basis Data for the Derivation of EU-LCI Values For
TEXTE 223/2020 Toxicological basis data for the derivation of EU- LCI values for neopentyl glycol, diisobutyl succinate, diisobutyl glutarate, 1,2- dimethoxyethane and 1,2-diethoxyethane Final report German Environment Agency TEXTE 223/2020 Ressortforschungsplan of the Federal Ministry for the Enviroment, Nature Conservation and Nuclear Safety Project No. (FKZ) 3719 62 205 0 Report No. FB000359/ENG Toxicological basis data for the derivation of EU-LCI values for neopentyl glycol, diisobutyl succinate, diisobutyl glutarate, 1,2- dimethoxyethane and 1,2-diethoxyethane Final report by Dr. Barbara Werschkun Wissenschaftsbüro, Berlin On behalf of the German Environment Agency Imprint Publisher Umweltbundesamt Wörlitzer Platz 1 06844 Dessau-Roßlau Tel: +49 340-2103-0 Fax: +49 340-2103-2285 [email protected] Internet: www.umweltbundesamt.de /umweltbundesamt.de /umweltbundesamt Report performed by: Wissenschaftsbüro Dr. Barbara Werschkun Monumentenstr. 31a 10829 Berlin Germany Report completed in: May 2020 Edited by: Section II 1.3 Indoor Hygiene, Health-related Environmental Impacts Dr. Ana Maria Scutaru Publication as pdf: http://www.umweltbundesamt.de/publikationen ISSN 1862-4804 Dessau-Roßlau, December 2020 The responsibility for the content of this publication lies with the author(s). TEXTE Toxicological basis data for the derivation of EU-LCI values for neopentyl glycol, diisobutyl succinate, diisobutyl glutarate, 1,2-dimethoxyethane and 1,2-diethoxyethane – Final report Abstract: Toxicological basis data for the derivation of EU-LCI values for neopentyl glycol, diisobutyl succinate, diisobutyl glutarate, 1,2-dimethoxyethane and 1,2-diethoxyethane The objective of this study was the evaluation of toxicological data for five substances as basis for the derivation of EU-LCI values. -
Glutaric Aciduria Lactic Acidosis Glutaryl-Coa Dehydrogenase Deficiency Short-Chain Monocarboxylic Acids
Pediat. Res. 13: 977-981 (1979) C6-C l~-dicarboxylicacid ketosis glutaric aciduria lactic acidosis glutaryl-CoA dehydrogenase deficiency short-chain monocarboxylic acids Ketotic Episodes in Glutaryl-CoA Dehydrogenase Deficiency (Glutaric Aciduria) NIELS GREGERSEN AND NIELS JACOB BRANDT Research Laboratory for Metabolic Disorders, University Department of Clinical Chemistry, Aarhus Kommunehospital, Aarhus, and Section of Clinical Genetics, University Department of Paediatrics, Obstetrics, and Gynaecology, Rigshospitalet, Copenhagen, Denmark Summaw the ketoacidosis, a pronounced lactic acidosis and lactic aciduria is seen in most cases. The present report, together with a recent A 7-yr-old boy with glutaryl-CoA dehydrogenase deficiency (glu- report of Goodman et al. (7), indicates that glutaryl-CoA dehy- taric aciduria), presenting periodic episodes of lethargy and keto- drogenase deficiency (glutaric aciduria) may present ketotic epi- sis, was studied during two such episodes. The urinary excretions sodes, similar to those of the other organic acidurias. of glutaric and 3-OH-glutaric acids were 3100-7900 and 460-660 The patient described by Goodman et al. (7) died in a Reye's &mg creatinine, respectively, during these episodes. Urine sam- syndromelike state. Our patient has had two episodes of ketosis ples collected before and after the attacks contained 100-5300 and and lethargy. During these episodes, the urinary metabolic profiles 230-370 &mg creatinine of glutaric acid and 3-OH-glutaric of organic acids were studied in detail, in an attempt to elucidate acids, respectively. During the episodes, glutaconic acid excretion the pathogenic mechanism leading to the severe clinical and rose from 14-89 to 93-630 pg/mg creatinine. -
Dibasic Acids for Nylon Manufacture
- e Report No. 75 DIBASIC ACIDS FOR NYLON MANUFACTURE by YEN-CHEN YEN October 1971 A private report by the PROCESS ECONOMICS PROGRAM STANFORD RESEARCH INSTITUTE MENLO PARK, CALIFORNIA CONTENTS INTRODUCTION, ....................... 1 SUMMARY .......................... 3 General Aspects ...................... 3 Technical Aspects ..................... 7 INDUSTRY STATUS ...................... 15 Applications and Consumption of Sebacic Acid ........ 15 Applications and Consumption of Azelaic Acid ........ 16 Applications of Dodecanedioic and Suberic Acids ...... 16 Applications of Cyclododecatriene and Cyclooctadiene .... 17 Producers ......................... 17 Prices ........................... 18 DIBASIC ACIDS FOR MANUFACTURE OF POLYAMIDES ........ 21 CYCLOOLIGOMERIZATIONOF BUTADIENE ............. 29 Chemistry ......................... 29 Ziegler Catalyst ..................... 30 Nickel Catalyst ..................... 33 Other Catalysts ..................... 34 Co-Cyclooligomerization ................. 34 Mechanism ........................ 35 By-products and Impurities ................ 37 Review of Processes .................... 38 A Process for Manufacture of Cyclododecatriene ....... 54 Process Description ................... 54 Process Discussion .................... 60 Cost Estimates ...................... 60 A Process for Manufacture of Cyclooctadiene ........ 65 Process Description ................... 65 Process Discussion .................... 70 Cost Estimates ...................... 70 A Process for Manufacture of Cyclodecadiene -
Microwave-Assisted Low-Temperature Dehydration Polycondensation of Dicarboxylic Acids and Diols
Polymer Journal (2011) 43, 1003–1007 & The Society of Polymer Science, Japan (SPSJ) All rights reserved 0032-3896/11 $32.00 www.nature.com/pj RAPID COMMUNICATION Microwave-assisted low-temperature dehydration polycondensation of dicarboxylic acids and diols Polymer Journal (2011) 43, 1003–1007; doi:10.1038/pj.2011.107; published online 26 October 2011 INTRODUCTION time (4100 h). Therefore, we next focused on has been no report concerning a Currently, because of increasing concerns identifying more active catalysts and found that non-thermal effect in microwave-assisted about damage to the environment, the devel- scandium and thulium bis(nonafluorobutane- polycondensation reactions,33,34 although opment of new, eco-friendly (industrially sulfonyl)imide ((Sc(NNf2)3) and (Tm(NNf2)3)) there has been a report that non-thermal relevant) chemical reactions and materials is were more efficient catalysts and allowed us microwaves have a role in the chain polymer- crucial. Aliphatic polyesters have attracted to obtain high-molecular-weight polyesters ization of a lactone.32 Therefore, we studied 4 much interest as environmentally benign, (Mn42.0Â10 ) from adipic acid (AdA) and microwave-assisted syntheses of polyesters at biodegradable polymers.1,2 In general, alipha- 3-methyl-1,5-pentanediol (MPD) at 60 1Cina a relatively low temperature (80 1C) using a tic polyesters are commercially produced by shortperiodoftime(24h)andwithasmaller microwave chamber equipped with a tem- polycondensation of a dicarboxylic acid and a amount of catalyst (0.1 mol%) than had pre- perature control, and the results are reported 1.1–1.5 mol excess of a diol at a temperature viously been possible.26 herein. -
Glutaric Acid Production by Systems Metabolic Engineering of an L-Lysine–Overproducing Corynebacterium Glutamicum
Glutaric acid production by systems metabolic engineering of an L-lysine–overproducing Corynebacterium glutamicum Taehee Hana, Gi Bae Kima, and Sang Yup Leea,b,c,1 aMetabolic and Biomolecular Engineering National Research Laboratory, Systems Metabolic Engineering and Systems Healthcare Cross-Generation Collaborative Laboratory, Department of Chemical and Biomolecular Engineering (BK21 Plus Program), Institute for the BioCentury, Korea Advanced Institute of Science and Technology, Yuseong-gu, 34141 Daejeon, Republic of Korea; bBioInformatics Research Center, Korea Advanced Institute of Science and Technology, Yuseong-gu, 34141 Daejeon, Republic of Korea; and cBioProcess Engineering Research Center, Korea Advanced Institute of Science and Technology, Yuseong-gu, 34141, Daejeon, Republic of Korea Contributed by Sang Yup Lee, October 6, 2020 (sent for review August 18, 2020; reviewed by Tae Seok Moon and Blake A. Simmons) There is increasing industrial demand for five-carbon platform processes rely on nonrenewable and toxic starting materials, chemicals, particularly glutaric acid, a widely used building block however. Thus, various approaches have been taken to biologi- chemical for the synthesis of polyesters and polyamides. Here we cally produce glutaric acid from renewable resources (13–19). report the development of an efficient glutaric acid microbial pro- Naturally, glutaric acid is a metabolite of L-lysine catabolism in ducer by systems metabolic engineering of an L-lysine–overproducing Pseudomonas species, in which L-lysine is converted to glutaric Corynebacterium glutamicum BE strain. Based on our previous study, acid by the 5-aminovaleric acid (AVA) pathway (20, 21). We an optimal synthetic metabolic pathway comprising Pseudomonas previously reported the development of the first glutaric acid- putida L-lysine monooxygenase (davB) and 5-aminovaleramide amido- producing Escherichia coli by introducing this pathway compris- hydrolase (davA) genes and C. -
APPENDIX G Acid Dissociation Constants
harxxxxx_App-G.qxd 3/8/10 1:34 PM Page AP11 APPENDIX G Acid Dissociation Constants § ϭ 0.1 M 0 ؍ (Ionic strength ( † ‡ † Name Structure* pKa Ka pKa ϫ Ϫ5 Acetic acid CH3CO2H 4.756 1.75 10 4.56 (ethanoic acid) N ϩ H3 ϫ Ϫ3 Alanine CHCH3 2.344 (CO2H) 4.53 10 2.33 ϫ Ϫ10 9.868 (NH3) 1.36 10 9.71 CO2H ϩ Ϫ5 Aminobenzene NH3 4.601 2.51 ϫ 10 4.64 (aniline) ϪO SNϩ Ϫ4 4-Aminobenzenesulfonic acid 3 H3 3.232 5.86 ϫ 10 3.01 (sulfanilic acid) ϩ NH3 ϫ Ϫ3 2-Aminobenzoic acid 2.08 (CO2H) 8.3 10 2.01 ϫ Ϫ5 (anthranilic acid) 4.96 (NH3) 1.10 10 4.78 CO2H ϩ 2-Aminoethanethiol HSCH2CH2NH3 —— 8.21 (SH) (2-mercaptoethylamine) —— 10.73 (NH3) ϩ ϫ Ϫ10 2-Aminoethanol HOCH2CH2NH3 9.498 3.18 10 9.52 (ethanolamine) O H ϫ Ϫ5 4.70 (NH3) (20°) 2.0 10 4.74 2-Aminophenol Ϫ 9.97 (OH) (20°) 1.05 ϫ 10 10 9.87 ϩ NH3 ϩ ϫ Ϫ10 Ammonia NH4 9.245 5.69 10 9.26 N ϩ H3 N ϩ H2 ϫ Ϫ2 1.823 (CO2H) 1.50 10 2.03 CHCH CH CH NHC ϫ Ϫ9 Arginine 2 2 2 8.991 (NH3) 1.02 10 9.00 NH —— (NH2) —— (12.1) CO2H 2 O Ϫ 2.24 5.8 ϫ 10 3 2.15 Ϫ Arsenic acid HO As OH 6.96 1.10 ϫ 10 7 6.65 Ϫ (hydrogen arsenate) (11.50) 3.2 ϫ 10 12 (11.18) OH ϫ Ϫ10 Arsenious acid As(OH)3 9.29 5.1 10 9.14 (hydrogen arsenite) N ϩ O H3 Asparagine CHCH2CNH2 —— —— 2.16 (CO2H) —— —— 8.73 (NH3) CO2H *Each acid is written in its protonated form. -
8342 RA Rosin Flux Paste
8342 RA Rosin Flux Paste MG Chemicals UK Limited Version No: A-1.0 2 Issue Date: 12/08/2019 Safety Data Sheet (Conforms to Regulation (EU) No 2015/830) Revision Date: 14/01/2021 L.REACH.GBR.EN SECTION 1 IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND OF THE COMPANY / UNDERTAKING 1.1. Product Identifier Product name 8342 Synonyms SDS Code: 8342; 8342-50G | UFI: MKH0-J0US-C00M-20WV Other means of identification RA Rosin Flux Paste 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses flux paste Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name MG Chemicals UK Limited MG Chemicals (Head office) Heame House, 23 Bilston Street, Sedgely Dudley DY3 1JA United Address 9347 - 193 Street Surrey V4N 4E7 British Columbia Canada Kingdom Telephone +(44) 1663 362888 +(1) 800-201-8822 Fax Not Available +(1) 800-708-9888 Website Not Available www.mgchemicals.com Email [email protected] [email protected] 1.4. Emergency telephone number Association / Organisation Verisk 3E (Access code: 335388) Emergency telephone numbers +(44) 20 35147487 Other emergency telephone +(0) 800 680 0425 numbers SECTION 2 HAZARDS IDENTIFICATION 2.1. Classification of the substance or mixture Classification according to regulation (EC) No 1272/2008 H334 - Respiratory Sensitizer Category 1, H319 - Eye Irritation Category 2, H317 - Skin Sensitizer Category 1 [CLP] [1] Legend: 1. Classified by Chemwatch; 2. Classification drawn from Regulation (EU) No 1272/2008 - Annex VI 2.2. Label elements Hazard pictogram(s) SIGNAL WORD DANGER Hazard statement(s) H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. -
Amt-10-1373-2017-Supplement.Pdf
Supplement of Atmos. Meas. Tech., 10, 1373–1386, 2017 http://www.atmos-meas-tech.net/10/1373/2017/ doi:10.5194/amt-10-1373-2017-supplement © Author(s) 2017. CC Attribution 3.0 License. Supplement of New insights into atmospherically relevant reaction systems using direct analysis in real-time mass spectrometry (DART-MS) Yue Zhao et al. Correspondence to: Barbara J. Finlayson-Pitts (bjfi[email protected]) The copyright of individual parts of the supplement might differ from the CC-BY 3.0 licence. 31 1. Particle size distributions for amine-reacted diacids and -cedrene secondary organic 32 aerosol (SOA) particles. 33 1.1 Amine-reacted diacid particles. 34 At the exit of the flow reactor, size distributions of the amine-reacted diacid particles were 35 collected using a scanning mobility particle sizer (SMPS, TSI) consisting of an electrostatic 36 classifier (model 3080), a long differential mobility analyzer (DMA, model 3081) and a 37 condensation particle counter (model 3025A or 3776). Typical surface weighted size 38 distributions for (a) malonic acid (C3), (b) glutaric acid (C5), and (c) pimelic acid (C7) reacted 39 particles are presented in Fig. S1, with size distribution statistics given in Table S1. To reflect 40 the ~10% loss of amine-diacid particles in the denuder, a correction factor, Cf, of 1.1 was applied 41 when calculating the fraction of amine in the particles, fp. 3 (a) Malonic acid particles 1.6 (b) Glutaric acid particles ) ) w/o denuder -3 w/o denuder -3 w/ denuder w/ denuder cm cm 1.2 2 2 2 cm cm -4 -4 0.8 (10 (10 p p 1 0.4 dS/dlogD dS/dlogD 0 0.0 100 1000 100 1000 D (nm) D (nm) 42 p p 3 (c) Pimelic acid particles w/o denuder ) -3 w/ denuder Figure S1. -
The Human Urine Metabolome
The Human Urine Metabolome Souhaila Bouatra1, Farid Aziat1, Rupasri Mandal1, An Chi Guo2, Michael R. Wilson2, Craig Knox2, Trent C. Bjorndahl1, Ramanarayan Krishnamurthy1, Fozia Saleem1, Philip Liu1, Zerihun T. Dame1, Jenna Poelzer1, Jessica Huynh1, Faizath S. Yallou1, Nick Psychogios3, Edison Dong1, Ralf Bogumil4, Cornelia Roehring4, David S. Wishart1,2,5* 1 Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada, 2 Department of Computing Sciences, University of Alberta, Edmonton, Alberta, Canada, 3 Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 4 BIOCRATES Life Sciences AG, Innsbruck, Austria, 5 National Institute for Nanotechnology, Edmonton, Alberta, Canada Abstract Urine has long been a ‘‘favored’’ biofluid among metabolomics researchers. It is sterile, easy-to-obtain in large volumes, largely free from interfering proteins or lipids and chemically complex. However, this chemical complexity has also made urine a particularly difficult substrate to fully understand. As a biological waste material, urine typically contains metabolic breakdown products from a wide range of foods, drinks, drugs, environmental contaminants, endogenous waste metabolites and bacterial by-products. Many of these compounds are poorly characterized and poorly understood. In an effort to improve our understanding of this biofluid we have undertaken a comprehensive, quantitative, metabolome-wide characterization of human urine. This involved both computer-aided literature mining and comprehensive, quantitative experimental assessment/validation. The experimental portion employed NMR spectroscopy, gas chromatography mass spectrometry (GC-MS), direct flow injection mass spectrometry (DFI/LC-MS/MS), inductively coupled plasma mass spectrometry (ICP-MS) and high performance liquid chromatography (HPLC) experiments performed on multiple human urine samples. -
Production of Malonic Acid Through the Fermentation of Glucose
University of Pennsylvania ScholarlyCommons Department of Chemical & Biomolecular Senior Design Reports (CBE) Engineering 4-20-2018 Production of Malonic Acid through the Fermentation of Glucose Emily P. Peters University of Pennsylvania, [email protected] Gabrielle J. Schlakman University of Pennsylvania, [email protected] Elise N. Yang University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/cbe_sdr Part of the Biochemical and Biomolecular Engineering Commons Peters, Emily P.; Schlakman, Gabrielle J.; and Yang, Elise N., "Production of Malonic Acid through the Fermentation of Glucose" (2018). Senior Design Reports (CBE). 107. https://repository.upenn.edu/cbe_sdr/107 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/cbe_sdr/107 For more information, please contact [email protected]. Production of Malonic Acid through the Fermentation of Glucose Abstract The overall process to produce malonic acid has not drastically changed in the past 50 years. The current process is damaging to the environment and costly, requiring high market prices. Lygos, Inc., a lab in Berkeley, California, has published a patent describing a way to produce malonic acid through the biological fermentation of genetically modified easty cells. This proposed technology is appealing as it is both better for the environment and economically friendly. For the process discussed in this report, genetically modified Pichia Kudriavzevii yeast cells will be purchased from the Lygos lab along with the negotiation of exclusive licensing rights to the technology. The cells will be grown in fermentation vessels, while being constantly fed oxygen, glucose and fermentation media. The cells will excrete malonic acid in the 101 hour fermentation process. -
United States Patent Office Patented Oct
3,471,548 United States Patent Office Patented Oct. 7, 1969 2 CH-NH 3,471,548 GAMMA-AMNO-BETA-(PARA-HALOPHENYL)- B-( )-(H-CH-C OOR." BUTYRIC ACDS AND THEIR ESTERS Heinrich Keberle, Basel, Johann Werner Faigle, Riehen, in which formulae R has the meaning given above, R' and Max Wilhelm, Allschwil, Switzerland, assignors to represents an acyl group, such as a lower alkanoyl group Ciba Corporation, New York, N.Y., a corporation of (e.g. an acetyl, propionyl or butyryl group), a phenyl Delaware lower alkanoyl group (e.g. a phenylacetyl group) or a No Drawing. Filed June 30, 1964, Ser. No. 379,365 benzoyl group, and -COOR' represents an esterified Claims priority, application Switzerland, July 9, 1963, carboxyl group (R' representing for example a lower 8,537/63; May 22, 1964, 6,729/64 10 alkyl or phenyl lower alkyl group, such as a methyl, ethyl, Int. C. C07c 101/00, 101/02 propyl, butyl or benzyl group). U.S. C. 260-471 14 Claims The hydrolysis is carried out in the usual manner, for example in the presence of an aqueous acid or alkali at room temperature or with heating. ABSTRACT OF THE DISCLOSURE 15 Depending on the reaction conditions and starting ma New compounds of the formula terials used the final products are obtained in the free CH-NH form or in the form of their salts which are likewise in cluded in the present invention. Thus, for example, basic, R-( >- E-CH-COOH neutral, acid or mixed salts, possibly also hemi-, mono-, R=halogen, e.g.